title: A new method of treatment of retinitis pigmentosa/pigmentary abiotrophy.
abstract: We report our results of treatment of pigmentary retinal abiotrophy with a drug known in the Soviet Union as Encad. Repeated courses of treatment twice a year for four to 14 years stabilized the pathologic process in more than 60% of 467 treated patients. We provide details of the treatment and specific indications and contraindications.
authors.affiliation: Moscow Helmholtz Research Institute of Eye Diseases, USSR.
authors.forename: L A
authors.initials: LA
authors.lastname: Katznelson
authors.forename: I P
authors.initials: IP
authors.lastname: Khoroshilova-Maslova
authors.forename: R F
authors.initials: RF
authors.lastname: Eliseyeva
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D003623:Dark Adaptation; D004305:Dose-Response Relationship, Drug; D004596:Electroretinography / Q000187:drug effects; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008875:Middle Aged; D009843:Oligoribonucleotides; D010786:Photoreceptor Cells / Q000187:drug effects / Q000648:ultrastructure; D051381:Rats; D012160:Retina / Q000187:drug effects / Q000648:ultrastructure; D012174:Retinitis Pigmentosa / Q000188:drug therapy*; D012265:Ribonucleotides / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects; D014794:Visual Fields / Q000187:drug effects
chemical_list: D009843:Oligoribonucleotides; D012265:Ribonucleotides; C031373:ENKAD